Project Grant K08CA293277
Award Date 4/1/25
Completion Date 3/31/30
Dollars Obligated $816K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
New York, NY 10016, USA
Similar Awards
- Federal Project Grant Award Summary The National Cancer Institute (NCI) awarded a $658,033 Project Grant to the University of Pennsylvania effective June 1, 2026, through May 31, 2031, under the Cancer Cause and Prevention Research program (CFDA 93.393). This project addresses pancreatic ductal adenocarcinoma (PDAC) through cancer interception strategies designed to eliminate premalignant lesions before progression to invasive cancer. The research focuses on translatable approaches to...
- The National Cancer Institute awarded MD Anderson Cancer Center a $141,195 Project Grant under the Cancer Research Manpower program (CFDA 93.398) on May 15, 2026, with completion targeted for April 30, 2028. This K99/R00 mentored research award supports biomedical training and cancer research workforce development focused on elucidating how tumor suppressor gene (TSG) deficiencies—specifically CDKN2A and SMAD4 alterations—modulate pancreatic ductal adenocarcinoma (PDAC) response to oncogenic...
- Federal Grant Award Summary Cedars-Sinai Medical Center received a $191,700 Project Grant from the National Cancer Institute (NCI) under the Cancer Research Manpower program (CFDA 93.398), effective September 1, 2025 through August 31, 2028. This award supports research investigating the etiology and tumor characteristics of early-onset pancreatic cancer. The project delivers two primary research products: (1) epidemiological analysis identifying modifiable risk factors associated with...
- Federal Project Grant Award Summary The National Cancer Institute (NCI), under the Cancer Research Manpower program (CFDA 93.398), awarded $188,080 to Massachusetts General Hospital's Research Management Division on August 22, 2025, for a two-year project extending through August 21, 2027. The award supports a mixed-methods research initiative titled "Enhancing Access in Pancreatic Cancer: Examining Facilitators and Barriers to Tertiary Referral for Complex Oncologic Surgical Care."...
- Federal Grant Award Summary Duke University's Office of Research Administration received a $120,403 Project Grant from the National Cancer Institute (NCI) under the Cancer Research Manpower program (CFDA 93.398), effective June 1, 2026 through May 31, 2027. The grant supports research development focused on pancreatic ductal adenocarcinoma (PDAC) detection and patient stratification for surgical intervention. The project employs ultrasensitive maximum depth sequencing (MDS) technology to...
- Federal Project Grant Award Summary The National Cancer Institute (NCI) awarded $109,080 to The Trustees of Columbia University in the City of New York (Health Sciences Division) on September 1, 2025, under the Cancer Research Manpower program (CFDA 93.398) to support a Phase II investigator-initiated, multicenter randomized controlled trial (RCT) evaluating predictive markers of response to a novel immunotherapeutic approach in treatment-naive metastatic pancreatic adenocarcinoma (MPDA). The...
- Federal Project Grant Award Summary The National Cancer Institute (NCI) awarded a Project Grant of $100,228 to The Trustees of Columbia University in the City of New York (Health Sciences Division) under the Cancer Research Manpower program (CFDA 93.398), with an award date of December 1, 2026, and a completion date of May 31, 2028. This grant supports research to identify and characterize fate determinants of basal-squamous pancreatic cancer, a particularly aggressive subtype associated with...
- Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded Dr. David Bayne at the University of California, San Francisco a K23 career development grant of $369,889 (awarded September 15, 2025; completion June 30, 2030) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). This award supports Dr. Bayne's research to develop and evaluate an intervention aimed at reducing loss to follow-up (LTFU) in urinary stone...
- Summary The University of Florida, in partnership with AdventHealth through a cooperative agreement with the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), is conducting clinical research to complete recruitment and long-term follow-up of patients with acute, relapsing acute, and chronic pancreatitis as part of the Chronic Pancreatitis Clinical Research Consortium (CPCRC)....
- Federal Project Grant Award Summary The National Cancer Institute (NCI) awarded $123,823 to the University of Maryland, Baltimore under the Cancer Research Manpower program (CFDA 93.398) effective June 1, 2026, through May 31, 2028. The project, titled "Transcriptomic, Genomic, and Microenvironmental Heterogeneity in Pancreatic Precancer: Subtyping, Classification, and Cross-Comparison," supports research and training initiatives focused on characterizing the molecular mechanisms...